Literature DB >> 9400940

Differential level of DSB repair fidelity effected by nuclear protein extracts derived from radiosensitive and radioresistant human tumour cells.

R A Britten1, D Liu, S Kuny, M J Allalunis-Turner.   

Abstract

A cell-free plasmid reactivation assay was used to determine the fidelity of DNA double-strand break (DSB) repair in a panel of eight DSB repair-proficient human tumour cell lines. Nuclear protein extracts derived from radiosensitive tumour cells were less capable of correctly rejoining EcoRI-induced DSBs than were similar extracts from radioresistant tumour cells. Linear regression analysis suggests that there was a significant (r2 = 0.84, P = 0.001, d.f. = 6) correlation between the fidelity of DSB rejoining and the SF2 values of the cell lines studied. This cell-free assay is clearly sensitive to differences in the nuclear protein composition that reflect the clinically relevant radiosensitivity of these cell lines. The fact that our cell-free assay yielded similar results to previous studies that used intracellular plasmid reactivation assays suggests that those differences in DSB mis-rejoining frequencies in radiosensitive and radioresistant cell lines may be due to inherent differences in nuclear protein composition and are not directly attributable to differences in proliferation rates between cell lines. The underlying cause for this association between DSB mis-rejoining frequencies and radiosensitivity is presently unknown, however restriction endonuclease mapping and polymerase chain reaction (PCR) amplification analysis revealed that approximately 40% of the mis-rejoined DSBs arose as a result of the deletion of between 40 and 440 base pairs. These data raise the possibility that the radiosensitivity of DSB repair-proficient human tumour cell lines may be partly determined by the predisposition of these cell lines to activate non-conservative DSB rejoining pathways.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9400940      PMCID: PMC2228177          DOI: 10.1038/bjc.1997.576

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  34 in total

1.  Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity.

Authors:  A M Taylor; D G Harnden; C F Arlett; S A Harcourt; A R Lehmann; S Stevens; B A Bridges
Journal:  Nature       Date:  1975-12-04       Impact factor: 49.962

Review 2.  Clonal variation of DNA repair in a human glioma cell line.

Authors:  S Powell; T J McMillan
Journal:  Radiother Oncol       Date:  1991-08       Impact factor: 6.280

3.  DNA-break repair, radioresistance of DNA synthesis, and camptothecin sensitivity in the radiation-sensitive irs mutants: comparisons to ataxia-telangiectasia cells.

Authors:  J Thacker; A N Ganesh
Journal:  Mutat Res       Date:  1990-03       Impact factor: 2.433

4.  Cell cycle-dependent repair of double-strand DNA breaks in a gamma-ray-sensitive Chinese hamster cell.

Authors:  A Giaccia; R Weinstein; J Hu; T D Stamato
Journal:  Somat Cell Mol Genet       Date:  1985-09

5.  The rejoining of double-strand breaks in DNA by human cell extracts.

Authors:  P North; A Ganesh; J Thacker
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

6.  The use of recombinant DNA plasmids for the determination of DNA-repair and recombination in cultured mammalian cells.

Authors:  R Cox; W K Masson; P G Debenham; M B Webb
Journal:  Br J Cancer Suppl       Date:  1984

7.  Inherent radiosensitivity testing of tumor biopsies obtained from patients with carcinoma of the cervix or endometrium.

Authors:  M J Allalunis-Turner; R G Pearcey; G M Barron; D A Buryn; J C Babiak; L H Honoré
Journal:  Radiother Oncol       Date:  1991-11       Impact factor: 6.280

8.  Radiosensitivity testing of human primary brain tumor specimens.

Authors:  M J Allalunis-Turner; G M Barron; R S Day; D S Fulton; R C Urtasun
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

9.  Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness.

Authors:  R A Britten; A J Evans; M J Allalunis-Turner; A J Franko; R G Pearcey
Journal:  Radiother Oncol       Date:  1996-05       Impact factor: 6.280

Review 10.  The radioresponsiveness of human tumours and the initial slope of the cell survival curve.

Authors:  J Deacon; M J Peckham; G G Steel
Journal:  Radiother Oncol       Date:  1984-12       Impact factor: 6.280

View more
  3 in total

1.  Development of a novel rapid assay to assess the fidelity of DNA double-strand-break repair in human tumour cells.

Authors:  S J Collis; V K Sangar; A Tighe; S A Roberts; N W Clarke; J H Hendry; G P Margison
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

2.  Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.

Authors:  Wei Yang; Liangli Wang; Gabriele Roehn; Robert D Pearlstein; Francis Ali-Osman; Hongjie Pan; Roland Goldbrunner; Matthew Krantz; Christoph Harms; Wulf Paschen
Journal:  Cancer Sci       Date:  2012-11-28       Impact factor: 6.716

3.  Modification of non-conservative double-strand break (DSB) rejoining activity after the induction of cisplatin resistance in human tumour cells.

Authors:  R A Britten; S Kuny; S Perdue
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.